25 XP   0   0   10

AlzChem Group AG
Buy, Hold or Sell?

Let's analyse Alzchem together

PenkeI guess you are interested in AlzChem Group AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AlzChem Group AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about AlzChem Group AG

I send you an email if I find something interesting about AlzChem Group AG.

Quick analysis of Alzchem (30 sec.)










What can you expect buying and holding a share of Alzchem? (30 sec.)

How much money do you get?

How much money do you get?
€1.14
When do you have the money?
1 year
How often do you get paid?
63.0%

What is your share worth?

Current worth
€34.59
Expected worth in 1 year
€54.31
How sure are you?
85.2%

+ What do you gain per year?

Total Gains per Share
€20.78
Return On Investment
47.2%

For what price can you sell your share?

Current Price per Share
€44.00
Expected price per share
€26.37 - €46.70
How sure are you?
50%

1. Valuation of Alzchem (5 min.)




Live pricePrice per Share (EOD)

€44.00

Intrinsic Value Per Share

€140.61 - €167.99

Total Value Per Share

€175.20 - €202.57

2. Growth of Alzchem (5 min.)




Is Alzchem growing?

Current yearPrevious yearGrowGrow %
How rich?$380.7m$153.7m$69.4m31.1%

How much money is Alzchem making?

Current yearPrevious yearGrowGrow %
Making money$12.9m$8.1m$4.7m37.1%
Net Profit Margin8.6%5.3%--

How much money comes from the company's main activities?

3. Financial Health of Alzchem (5 min.)




4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  

What can you expect buying and holding a share of Alzchem? (5 min.)

Welcome investor! Alzchem's management wants to use your money to grow the business. In return you get a share of Alzchem.

What can you expect buying and holding a share of Alzchem?

First you should know what it really means to hold a share of Alzchem. And how you can make/lose money.

Speculation

The Price per Share of Alzchem is €44.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alzchem.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alzchem, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €34.59. Based on the TTM, the Book Value Change Per Share is €4.93 per quarter. Based on the YOY, the Book Value Change Per Share is €0.92 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.26 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alzchem.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.302.9%1.272.9%0.801.8%0.771.8%0.701.6%
Usd Book Value Change Per Share20.0345.5%5.3412.1%0.992.3%1.513.4%1.393.1%
Usd Dividend Per Share0.000.0%0.280.6%1.122.5%0.761.7%0.621.4%
Usd Total Gains Per Share20.0345.5%5.6212.8%2.114.8%2.275.2%2.014.6%
Usd Price Per Share39.92-27.57-19.59-22.49-17.86-
Price to Earnings Ratio7.70-5.93-6.25-9.80-7.95-
Price-to-Total Gains Ratio1.99-41.88-9.66-16.02-11.50-
Price to Book Ratio1.07-1.31-1.30-2.18-1.73-
Price-to-Total Gains Ratio1.99-41.88-9.66-16.02-11.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share47.5992
Number of shares21
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.280.76
Usd Book Value Change Per Share5.341.51
Usd Total Gains Per Share5.622.27
Gains per Quarter (21 shares)118.0047.71
Gains per Year (21 shares)472.01190.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12444846264127181
248896934128254372
37213441406192381563
49517931878256508754
511922412350320635945
6143268928223837621136
7167313732944478891327
81913585376651110151518
92154033423857511421709
102394482471063912691900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%27.00.00.0100.0%27.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%18.08.01.066.7%18.08.01.066.7%
Dividend per Share1.00.03.025.0%9.00.03.075.0%16.00.04.080.0%17.00.010.063.0%17.00.010.063.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%23.04.00.085.2%23.04.00.085.2%

Fundamentals of Alzchem

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany.

Fundamental data was last updated by Penke on 2024-05-13 05:29:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of AlzChem Group AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alzchem earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 7.9% means that €0.08 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AlzChem Group AG:

  • The MRQ is 7.9%. The company is making a profit. +1
  • The TTM is 8.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.9%TTM8.6%-0.7%
TTM8.6%YOY5.3%+3.3%
TTM8.6%5Y6.1%+2.6%
5Y6.1%10Y5.8%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9%4.0%+3.9%
TTM8.6%4.0%+4.6%
YOY5.3%5.2%+0.1%
5Y6.1%5.8%+0.3%
10Y5.8%5.8%+0.0%
1.1.2. Return on Assets

Shows how efficient Alzchem is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • 2.7% Return on Assets means that Alzchem generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AlzChem Group AG:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.8%-0.1%
TTM2.8%YOY1.7%+1.0%
TTM2.8%5Y1.8%+0.9%
5Y1.8%10Y1.7%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%1.0%+1.7%
TTM2.8%1.0%+1.8%
YOY1.7%1.4%+0.3%
5Y1.8%1.5%+0.3%
10Y1.7%1.6%+0.1%
1.1.3. Return on Equity

Shows how efficient Alzchem is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • 6.8% Return on Equity means Alzchem generated €0.07 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AlzChem Group AG:

  • The MRQ is 6.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.8%TTM7.3%-0.5%
TTM7.3%YOY5.4%+1.9%
TTM7.3%5Y7.2%+0.2%
5Y7.2%10Y6.8%+0.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8%1.9%+4.9%
TTM7.3%1.8%+5.5%
YOY5.4%2.6%+2.8%
5Y7.2%2.6%+4.6%
10Y6.8%2.7%+4.1%

1.2. Operating Efficiency of AlzChem Group AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alzchem is operating .

  • Measures how much profit Alzchem makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • An Operating Margin of 12.0% means the company generated €0.12  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AlzChem Group AG:

  • The MRQ is 12.0%. The company is operating less efficient.
  • The TTM is 13.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM13.2%-1.2%
TTM13.2%YOY6.5%+6.6%
TTM13.2%5Y9.0%+4.2%
5Y9.0%10Y8.8%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0%7.9%+4.1%
TTM13.2%3.4%+9.8%
YOY6.5%6.9%-0.4%
5Y9.0%7.5%+1.5%
10Y8.8%7.2%+1.6%
1.2.2. Operating Ratio

Measures how efficient Alzchem is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are €0.88 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of AlzChem Group AG:

  • The MRQ is 0.880. The company is less efficient in keeping operating costs low.
  • The TTM is 1.080. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.880TTM1.080-0.200
TTM1.080YOY0.946+0.134
TTM1.0805Y0.955+0.125
5Y0.95510Y0.943+0.012
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8801.542-0.662
TTM1.0801.538-0.458
YOY0.9461.472-0.526
5Y0.9551.456-0.501
10Y0.9431.239-0.296

1.3. Liquidity of AlzChem Group AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alzchem is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 2.52 means the company has €2.52 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of AlzChem Group AG:

  • The MRQ is 2.525. The company is able to pay all its short-term debts. +1
  • The TTM is 2.394. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.525TTM2.394+0.130
TTM2.394YOY1.705+0.689
TTM2.3945Y2.058+0.336
5Y2.05810Y1.949+0.109
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5251.831+0.694
TTM2.3941.892+0.502
YOY1.7051.897-0.192
5Y2.0581.918+0.140
10Y1.9491.759+0.190
1.3.2. Quick Ratio

Measures if Alzchem is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • A Quick Ratio of 1.30 means the company can pay off €1.30 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AlzChem Group AG:

  • The MRQ is 1.298. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.041. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.298TTM1.041+0.257
TTM1.041YOY0.686+0.354
TTM1.0415Y0.902+0.138
5Y0.90210Y0.782+0.120
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2980.789+0.509
TTM1.0410.841+0.200
YOY0.6860.949-0.263
5Y0.9021.044-0.142
10Y0.7821.035-0.253

1.4. Solvency of AlzChem Group AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alzchem assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alzchem to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.21 means that Alzchem assets are financed with 21.4% credit (debt) and the remaining percentage (100% - 21.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AlzChem Group AG:

  • The MRQ is 0.214. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.525. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.525-0.311
TTM0.525YOY0.670-0.145
TTM0.5255Y0.714-0.190
5Y0.71410Y0.703+0.011
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2140.426-0.212
TTM0.5250.431+0.094
YOY0.6700.421+0.249
5Y0.7140.432+0.282
10Y0.7030.439+0.264
1.4.2. Debt to Equity Ratio

Measures if Alzchem is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alzchem to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 53.5% means that company has €0.54 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AlzChem Group AG:

  • The MRQ is 0.535. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.420. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.535TTM1.420-0.885
TTM1.420YOY2.067-0.647
TTM1.4205Y3.118-1.697
5Y3.11810Y3.139-0.022
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5350.765-0.230
TTM1.4200.770+0.650
YOY2.0670.731+1.336
5Y3.1180.814+2.304
10Y3.1390.851+2.288

2. Market Valuation of AlzChem Group AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Alzchem generates.

  • Above 15 is considered overpriced but always compare Alzchem to the Specialty Chemicals industry mean.
  • A PE ratio of 7.70 means the investor is paying €7.70 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AlzChem Group AG:

  • The EOD is 9.180. Based on the earnings, the company is underpriced. +1
  • The MRQ is 7.699. Based on the earnings, the company is underpriced. +1
  • The TTM is 5.926. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.180MRQ7.699+1.481
MRQ7.699TTM5.926+1.773
TTM5.926YOY6.246-0.320
TTM5.9265Y9.799-3.874
5Y9.79910Y7.953+1.846
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD9.18017.179-7.999
MRQ7.69915.794-8.095
TTM5.92615.817-9.891
YOY6.24616.343-10.097
5Y9.79919.631-9.832
10Y7.95323.565-15.612
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AlzChem Group AG:

  • The EOD is 3.346. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.806. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.538. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.346MRQ2.806+0.540
MRQ2.806TTM4.538-1.732
TTM4.538YOY6.065-1.527
TTM4.5385Y-2.036+6.575
5Y-2.03610Y-1.134-0.902
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD3.346-0.467+3.813
MRQ2.806-0.728+3.534
TTM4.5382.909+1.629
YOY6.065-0.181+6.246
5Y-2.0362.849-4.885
10Y-1.1342.960-4.094
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alzchem is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 1.07 means the investor is paying €1.07 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of AlzChem Group AG:

  • The EOD is 1.272. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.067. Based on the equity, the company is underpriced. +1
  • The TTM is 1.313. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.272MRQ1.067+0.205
MRQ1.067TTM1.313-0.247
TTM1.313YOY1.302+0.012
TTM1.3135Y2.178-0.865
5Y2.17810Y1.732+0.446
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD1.2721.795-0.523
MRQ1.0671.691-0.624
TTM1.3131.766-0.453
YOY1.3022.136-0.834
5Y2.1782.314-0.136
10Y1.7322.758-1.026
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of AlzChem Group AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--18.5154.932+275%0.916+1922%1.397+1225%1.281+1345%
Book Value Per Share--34.58820.275+71%13.966+148%11.282+207%9.776+254%
Current Ratio--2.5252.394+5%1.705+48%2.058+23%1.949+30%
Debt To Asset Ratio--0.2140.525-59%0.670-68%0.714-70%0.703-70%
Debt To Equity Ratio--0.5351.420-62%2.067-74%3.118-83%3.139-83%
Dividend Per Share---0.262-100%1.037-100%0.703-100%0.575-100%
Eps--1.1981.173+2%0.737+62%0.713+68%0.647+85%
Free Cash Flow Per Share--3.2872.089+57%-0.023+101%0.918+258%0.792+315%
Free Cash Flow To Equity Per Share--3.0501.175+160%0.326+834%0.573+432%0.642+375%
Gross Profit Margin--1.0000.830+20%0.823+22%0.842+19%0.787+27%
Intrinsic Value_10Y_max--167.987--------
Intrinsic Value_10Y_min--140.609--------
Intrinsic Value_1Y_max--5.235--------
Intrinsic Value_1Y_min--5.136--------
Intrinsic Value_3Y_max--24.569--------
Intrinsic Value_3Y_min--23.277--------
Intrinsic Value_5Y_max--54.560--------
Intrinsic Value_5Y_min--49.880--------
Market Cap447757200.000+16%375505470.000259368446.250+45%184318233.750+104%211581537.120+77%168198861.719+123%
Net Profit Margin--0.0790.086-8%0.053+49%0.061+31%0.058+36%
Operating Margin--0.1200.132-9%0.065+83%0.090+33%0.088+36%
Operating Ratio--0.8801.080-18%0.946-7%0.955-8%0.943-7%
Pb Ratio1.272+16%1.0671.313-19%1.302-18%2.178-51%1.732-38%
Pe Ratio9.180+16%7.6995.926+30%6.246+23%9.799-21%7.953-3%
Price Per Share44.000+16%36.90025.488+45%18.113+104%20.785+78%16.509+124%
Price To Free Cash Flow Ratio3.346+16%2.8064.538-38%6.065-54%-2.036+173%-1.134+140%
Price To Total Gains Ratio2.376+16%1.99341.877-95%9.664-79%16.019-88%11.498-83%
Quick Ratio--1.2981.041+25%0.686+89%0.902+44%0.782+66%
Return On Assets--0.0270.028-2%0.017+56%0.018+49%0.017+63%
Return On Equity--0.0680.073-7%0.054+26%0.072-5%0.068+0%
Total Gains Per Share--18.5155.194+256%1.952+848%2.100+782%1.856+897%
Usd Book Value--380764391.400223204548.600+71%153751095.450+148%124219199.520+207%107780655.533+253%
Usd Book Value Change Per Share--20.0305.335+275%0.991+1922%1.511+1225%1.386+1345%
Usd Book Value Per Share--37.41721.934+71%15.109+148%12.205+207%10.576+254%
Usd Dividend Per Share---0.284-100%1.121-100%0.761-100%0.622-100%
Usd Eps--1.2961.269+2%0.798+62%0.772+68%0.700+85%
Usd Free Cash Flow--36186210.00022993388.550+57%-255034.350+101%10115154.540+258%8748156.000+314%
Usd Free Cash Flow Per Share--3.5562.260+57%-0.025+101%0.993+258%0.857+315%
Usd Free Cash Flow To Equity Per Share--3.2991.271+160%0.353+834%0.620+432%0.695+375%
Usd Market Cap484383738.960+16%406221817.446280584785.153+45%199395465.271+104%228888906.856+77%181957528.607+123%
Usd Price Per Share47.599+16%39.91827.572+45%19.594+104%22.485+78%17.859+124%
Usd Profit--13191469.20012916692.000+2%8118368.100+62%7855328.430+68%7134110.400+85%
Usd Revenue--166188279.600147087748.350+13%152333667.000+9%125597845.440+32%118232886.933+41%
Usd Total Gains Per Share--20.0305.619+256%2.112+848%2.272+782%2.008+897%
 EOD+4 -4MRQTTM+27 -9YOY+31 -55Y+30 -610Y+31 -5

3.2. Fundamental Score

Let's check the fundamental score of AlzChem Group AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.180
Price to Book Ratio (EOD)Between0-11.272
Net Profit Margin (MRQ)Greater than00.079
Operating Margin (MRQ)Greater than00.120
Quick Ratio (MRQ)Greater than11.298
Current Ratio (MRQ)Greater than12.525
Debt to Asset Ratio (MRQ)Less than10.214
Debt to Equity Ratio (MRQ)Less than10.535
Return on Equity (MRQ)Greater than0.150.068
Return on Assets (MRQ)Greater than0.050.027
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of AlzChem Group AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.111
Ma 20Greater thanMa 5043.735
Ma 50Greater thanMa 10040.122
Ma 100Greater thanMa 20032.345
OpenGreater thanClose43.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets447,808
Total Liabilities95,835
Total Stockholder Equity179,019
 As reported
Total Liabilities 95,835
Total Stockholder Equity+ 179,019
Total Assets = 447,808

Assets

Total Assets447,808
Total Current Assets241,962
Long-term Assets205,846
Total Current Assets
Cash And Cash Equivalents 35,997
Net Receivables 88,388
Inventory 97,393
Other Current Assets 20,184
Total Current Assets  (as reported)241,962
Total Current Assets  (calculated)241,962
+/- 0
Long-term Assets
Property Plant Equipment 181,582
Intangible Assets 3,751
Long-term Assets Other 20,513
Long-term Assets  (as reported)205,846
Long-term Assets  (calculated)205,846
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities95,835
Long-term Liabilities172,954
Total Stockholder Equity179,019
Total Current Liabilities
Other Current Liabilities 95,835
Total Current Liabilities  (as reported)95,835
Total Current Liabilities  (calculated)95,835
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)172,954
Long-term Liabilities  (calculated)0
+/- 172,954
Total Stockholder Equity
Common Stock179,019
Total Stockholder Equity (as reported)179,019
Total Stockholder Equity (calculated)179,019
+/-0
Other
Cash and Short Term Investments 35,997
Common Stock Shares Outstanding 10,162
Liabilities and Stockholders Equity 274,854
Net Debt -35,997
Net Working Capital 146,127



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302011-12-312011-06-302010-12-312010-06-30
> Total Assets 
64
55
22
17
14
14
15
25
19
37
56
64
0
77
272,855
280,181
295,481
306,614
313,551
347,577
359,800
344,252
342,583
338,938
354,324
342,474
354,296
359,160
365,560
381,270
377,667
403,974
427,886
436,683
422,860
435,372
419,234
429,130
424,677
447,808
447,808424,677429,130419,234435,372422,860436,683427,886403,974377,667381,270365,560359,160354,296342,474354,324338,938342,583344,252359,800347,577313,551306,614295,481280,181272,855770645637192515141417225564
   > Total Current Assets 
64
55
22
17
14
14
15
13
19
14
22
12
0
14
139,552
137,517
150,972
152,994
142,551
165,412
169,737
147,007
130,603
136,188
145,722
132,377
132,455
140,371
144,988
159,194
152,582
187,378
217,913
226,673
214,637
228,657
215,800
227,563
216,581
241,962
241,962216,581227,563215,800228,657214,637226,673217,913187,378152,582159,194144,988140,371132,455132,377145,722136,188130,603147,007169,737165,412142,551152,994150,972137,517139,552140122214191315141417225564
       Cash And Cash Equivalents 
64
47
14
8
4
13
15
13
17
7
12
2
0
3
12,742
12,802
12,926
11,364
12,857
17,734
14,025
9,980
9,061
10,057
10,099
12,609
17,117
11,234
10,783
6,905
8,285
8,435
10,196
9,506
9,243
8,126
9,299
16,732
11,883
35,997
35,99711,88316,7329,2998,1269,2439,50610,1968,4358,2856,90510,78311,23417,11712,60910,09910,0579,0619,98014,02517,73412,85711,36412,92612,80212,7423021271713151348144764
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36
499
0
0
190
2,666
2,150
-624
189
0
6
0
355
0
0
0
446
0
0
0
375
4,423
3,066
1,748
5,902
0
05,9021,7483,0664,423375000446000355060189-6242,1502,666190004993600000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,453
0
0
66,536
0
0
53,624
45,736
39,390
51,625
62,148
46,186
40,156
62,977
66,829
77,731
49,430
71,324
80,820
85,685
67,488
76,838
57,202
63,069
84,327
88,388
88,38884,32763,06957,20276,83867,48885,68580,82071,32449,43077,73166,82962,97740,15646,18662,14851,62539,39045,73653,6240066,5360079,45300000000000000
       Other Current Assets 
0
8
8
9
9
1
0
0
2
7
10
9
0
11
-1
52,911
63,144
-1
50,648
60,900
69,957
63,572
47,146
51,625
62,148
46,186
48,058
62,977
66,829
77,731
58,043
-1
80,820
85,685
82,701
23,733
19,741
22,493
6,991
20,184
20,1846,99122,49319,74123,73382,70185,68580,820-158,04377,73166,82962,97748,05846,18662,14851,62547,14663,57269,95760,90050,648-163,14452,911-11109107200199880
   > Long-term Assets 
0
0
0
0
0
0
0
12
0
23
34
52
0
63
133,303
142,664
144,509
155,048
171,000
182,165
190,063
198,753
211,980
202,750
208,602
210,097
221,841
218,789
220,572
222,076
225,085
216,595
209,973
210,010
208,223
206,715
203,434
201,566
208,096
205,846
205,846208,096201,566203,434206,715208,223210,010209,973216,595225,085222,076220,572218,789221,841210,097208,602202,750211,980198,753190,063182,165171,000155,048144,509142,664133,3036305234230120000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,399
115,131
117,060
128,433
144,265
153,005
158,545
163,961
175,472
172,831
171,777
172,819
183,586
183,443
184,726
184,581
186,493
185,340
187,251
187,442
187,776
185,204
176,826
176,435
182,136
181,582
181,582182,136176,435176,826185,204187,776187,442187,251185,340186,493184,581184,726183,443183,586172,819171,777172,831175,472163,961158,545153,005144,265128,433117,060115,131106,39900000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,009
0
0
870
0
0
0
1,541
1,410
1,360
1,311
1,810
1,670
1,767
1,754
2,329
0
0
0
2,954
2,997
8,514
8,369
3,664
3,751
3,7513,6648,3698,5142,9972,9540002,3291,7541,7671,6701,8101,3111,3601,4101,541000870001,009000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
-1,428
0
0
0
-1,508
43,994
28,489
35,445
35,947
57,000
33,656
34,059
35,721
47,640
1
20,435
19,994
26,828
0
18,088
1
0
0
00118,088026,82819,99420,435147,64035,72134,05933,65657,00035,94735,44528,48943,994-1,508000-1,42800000100000000000
> Total Liabilities 
38
38
5
5
5
12
16
25
18
37
56
64
0
77
214,953
222,287
230,716
229,736
245,160
279,902
300,648
287,882
281,233
257,830
291,599
278,463
285,638
276,412
283,786
299,962
288,103
290,023
295,796
297,444
276,914
284,146
270,900
267,688
261,118
95,835
95,835261,118267,688270,900284,146276,914297,444295,796290,023288,103299,962283,786276,412285,638278,463291,599257,830281,233287,882300,648279,902245,160229,736230,716222,287214,953770645637182516125553838
   > Total Current Liabilities 
0
32
5
0
0
0
0
0
0
25
55
54
0
76
73,210
76,009
84,206
74,950
81,157
76,778
91,483
69,991
60,485
61,316
73,051
59,296
59,871
63,056
70,959
82,635
76,125
104,718
141,166
148,098
132,106
107,708
97,782
102,282
82,631
95,835
95,83582,631102,28297,782107,708132,106148,098141,166104,71876,12582,63570,95963,05659,87159,29673,05161,31660,48569,99191,48376,77881,15774,95084,20676,00973,2107605455250000005320
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,942
22,122
29,580
0
25,353
0
33,851
0
13,641
0
27,041
0
14,338
0
14,757
0
12,295
28,483
62,487
0
68,115
0
23,381
0
10,446
0
010,446023,381068,115062,48728,48312,295014,757014,338027,041013,641033,851025,353029,58022,12215,94200000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,443
0
11,935
0
25,473
0
12,704
0
12,407
0
10,490
26,708
60,750
0
66,408
0
21,788
0
8,833
0
08,833021,788066,408060,75026,70810,490012,407012,704025,473011,935032,44300000000000000000000
       Accounts payable 
0
32
0
0
0
0
0
0
0
2
16
0
0
1
22,449
28,199
24,587
0
30,863
0
25,606
0
24,069
0
23,871
0
20,880
0
28,537
0
32,780
42,358
44,778
0
37,386
0
38,709
0
31,554
0
031,554038,709037,386044,77842,35832,780028,537020,880023,871024,069025,606030,863024,58728,19922,4491001620000000320
       Other Current Liabilities 
0
0
5
0
0
0
0
0
0
23
39
54
0
75
24,735
4,566
25,716
74,950
3,387
76,778
26,619
69,991
2,193
61,316
19,094
59,296
2,458
63,056
23,599
82,635
4,629
33,877
33,901
148,098
26,605
107,708
29,664
102,282
32,467
95,835
95,83532,467102,28229,664107,70826,605148,09833,90133,8774,62982,63523,59963,0562,45859,29619,09461,3162,19369,99126,61976,7783,38774,95025,7164,56624,735750543923000000500
   > Long-term Liabilities 
38
6
0
5
5
12
16
25
17
12
2
10
0
2
141,743
146,278
146,510
154,786
164,003
203,124
209,165
217,891
220,748
196,514
218,548
219,167
225,767
213,356
212,827
217,327
211,978
185,305
154,630
149,346
144,808
176,438
173,118
165,406
178,487
172,954
172,954178,487165,406173,118176,438144,808149,346154,630185,305211,978217,327212,827213,356225,767219,167218,548196,514220,748217,891209,165203,124164,003154,786146,510146,278141,743201021217251612550638
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,722
0
48,141
0
43,346
0
0
0
0
0
0
0
0
0
00000000043,346048,141054,72200000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
217,891
162,291
196,514
166,626
219,167
171,045
213,356
164,686
217,327
168,632
185,304
117,017
149,346
112,688
0
116,029
165,406
0
0
00165,406116,0290112,688149,346117,017185,304168,632217,327164,686213,356171,045219,167166,626196,514162,291217,891000000000000000000000
> Total Stockholder Equity
27
17
17
13
9
2
-1
-41,474
1
-41,494
-41,494
-51
0
-51
55,687
55,670
62,559
76,878
66,971
66,255
57,645
56,370
59,758
79,516
61,047
62,333
66,895
80,985
79,926
79,460
87,630
111,974
130,070
137,219
144,012
149,292
146,314
159,422
161,625
179,019
179,019161,625159,422146,314149,292144,012137,219130,070111,97487,63079,46079,92680,98566,89562,33361,04779,51659,75856,37057,64566,25566,97176,87862,55955,67055,687-510-51-41,494-41,4941-41,474-12913171727
   Common Stock
310
310
310
310
310
310
310
310
310
310
310
310
0
310
11,000
101,763
101,763
0
101,763
0
101,763
57,877
101,763
81,108
101,763
64,011
101,763
82,748
101,763
81,308
101,763
101,763
101,763
139,239
101,763
151,226
101,763
161,442
101,763
179,019
179,019101,763161,442101,763151,226101,763139,239101,763101,763101,76381,308101,76382,748101,76364,011101,76381,108101,76357,877101,7630101,7630101,763101,76311,0003100310310310310310310310310310310310310
   Retained Earnings 
-41,757
0
0
-41,771
-41,775
-41,782
-41,785
-41,784
-41,803
-41,804
-41,804
-361
0
-361
47,493
49,047
23,943
0
60,478
0
19,030
0
21,142
0
72,750
0
28,279
0
42,317
0
101,127
108,825
108,276
0
121,044
0
125,223
0
144,979
0
0144,9790125,2230121,0440108,276108,825101,127042,317028,279072,750021,142019,030060,478023,94349,04747,493-3610-361-41,804-41,804-41,803-41,784-41,785-41,782-41,775-41,77100-41,757
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,981
0
24,981
0
24,981
0
24,981
0
24,981
0
0
0
0
0
0
0
0
0
00000000024,981024,981024,981024,981024,9810000000000000000000000
   Treasury Stock000000000-1,0090-1,0070000000000000000000000000000
   Other Stockholders Equity 
41,474
-293
-293
41,474
41,474
41,474
41,474
41,474
41,494
41,494
41,494
51
0
51
-2,806
50,615
-63,147
76,878
58,820
66,255
-63,148
56,370
108,769
79,516
-113,466
62,333
125,183
80,985
-64,154
79,460
-115,260
-98,614
-79,969
0
-78,795
-151,226
-80,672
-2,020
-63,478
0
0-63,478-2,020-80,672-151,226-78,7950-79,969-98,614-115,26079,460-64,15480,985125,18362,333-113,46679,516108,76956,370-63,14866,25558,82076,878-63,14750,615-2,8065105141,49441,49441,49441,47441,47441,47441,47441,474-293-29341,474



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue540,649
Cost of Revenue-224,085
Gross Profit316,564316,564
 
Operating Income (+$)
Gross Profit316,564
Operating Expense-259,619
Operating Income56,94556,945
 
Operating Expense (+$)
Research Development11,413
Selling General Administrative12,731
Selling And Marketing Expenses21,048
Operating Expense259,61945,192
 
Net Interest Income (+$)
Interest Income2,470
Interest Expense-2,614
Other Finance Cost-2,827
Net Interest Income-2,971
 
Pretax Income (+$)
Operating Income56,945
Net Interest Income-2,971
Other Non-Operating Income Expenses0
Income Before Tax (EBT)48,18960,998
EBIT - interestExpense = 49,628
48,018
37,235
Interest Expense2,614
Earnings Before Interest and Taxes (EBIT)52,24250,803
Earnings Before Interest and Taxes (EBITDA)78,142
 
After tax Income (+$)
Income Before Tax48,189
Tax Provision-11,445
Net Income From Continuing Ops30,47936,744
Net Income34,621
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses488,407
Total Other Income/Expenses Net-4,0532,971
 

Technical Analysis of Alzchem
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alzchem. The general trend of Alzchem is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alzchem's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AlzChem Group AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 45.60 < 46.70.

The bearish price targets are: 40.96 > 39.02 > 26.37.

Tweet this
AlzChem Group AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AlzChem Group AG. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I